Respiratory Therapeutics is the Largest Segment Driving the Growth of Pulmonary Drugs Market SWOT Analysis Strength: Wide range of drugs available for treatment of pulmonary diseases. Growing awareness regarding respiratory illnesses.Weakness: High costs associated with development of novel treatment regimens. Side effects of few drugs discourage compliance. Opportunity: Rising pollution and urbanization in developing nations present an opportunity. Untapped rural markets yet to adopt...
0 Shares
1396 Views
0 Reviews